Third Affiliated Hospital, Sun Yat-sen University

This study tests a new blood-filtering method (DPCAS+LPE) for people with sudden liver failure and sepsis. About 192 adults will receive either this new treatment or standard plasma exchange. The goal is to see if the new method lowers death rates at 4 and 12 weeks and reduces in…

This study involves over 16,000 people with chronic hepatitis B across three hospitals in China. The goal is to increase the number of patients referred to liver specialists and started on antiviral treatment. Researchers will also measure how treatment affects patients' quality …

This study looks at whether the drug ofatumumab can reduce nerve damage in people with relapsing multiple sclerosis (RMS). Researchers will measure a blood marker called sNfL, which indicates nerve injury. About 80 adults with RMS will receive ofatumumab and be followed in a real…